Inappropriate Sinus Tachycardia Registry

NCT05107635 · tracked via the Priya Life Science USA tracker

Sponsor

AtriCure, Inc.

Phase

Observational

Started

2022-03-01

Last updated

2026-08-27

Condition(s) studied

Inappropriate Sinus TachycardiaPostural Tachycardia Syndrome

Investigational drug(s) / intervention(s)

AtriCure Commercially Available Devices

AtriCure Commercially Available Devices: Epicardial and endocardial hybrid ablation procedure used to treat the IST or POTS using AtriCure commercially available devices.

Study summary

The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.

Eligibility

Sex

ALL

Min age

18 Years

Max age

100 Years

Healthy volunteers

Inclusion Criteria: 1. Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices. 2. Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements Exclusion Criteria: 1. Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS. 2. Subject with exclusion criteria required by FDA or local governance

Primary outcome measure(s)

AtriCure commercially available devices used to treat IST or POTS — 5 years
The IST Registry will attempt to enroll all eligible patients at registry sites who have already had or are scheduled to have a procedure to treat IST/POTS that includes the use of at least one commercially available AtriCure cardiac ablation devices.

Trial sites (15)

Facility	City	Region	Status
Loma Linda University Health	Loma Linda	California	Recruiting
Stanford University	Palo Alto	California	Recruiting
Sequoia Hospital	Redwood City	California	Recruiting
University of Florida	Gainesville	Florida	Recruiting
HCA Osceola Regional Medical Center	Kissimmee	Florida	Recruiting
Sarasota Memorial Hospital	Sarasota	Florida	Recruiting
Kansas City Cardiac Arrhythmia Research	Kansas City	Kansas	Recruiting
MedStar Health Research Institute	Hyattsville	Maryland	Recruiting
The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital	Cincinnati	Ohio	Recruiting
Texas Cardiac Arrhythmia Research Foundation	Austin	Texas	Recruiting
Intermountain Medical Center	Murray	Utah	Recruiting
Swedish Health Services	Seattle	Washington	Recruiting
Universitair Ziekenhuis Brussels	Brussels	Belgium	Recruiting
IRCCS Ospedale San Raffaele	San Raffaele	Italy	Recruiting
Central Clinic Hospital	Warsaw	Poland	Recruiting

More AtriCure, Inc. trials in the USA

Tracking Results of Ablations to Combat AF Registry Generation 2 Recruiting

BoxX-NoAF Clinical Trial Recruiting

CONVERGE Post-Approval Study (PAS) Active, not recruiting

HEAL-IST IDE Trial Active, not recruiting

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial Active, not recruiting

Other trials for the same condition

HEAL-IST IDE Trial Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05107635 on ClinicalTrials.gov ↗ ← All trials in the USA